Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,003,626 papers from all fields of science
Search
Sign In
Create Free Account
TAC Regimen
Known as:
TAC
, Taxotere-Adriamycin-Cytoxan Regimen
An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer. It includes the drugs docetaxel (Taxotere…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Cyclophosphamide
Doxorubicin
docetaxel
invasive breast cancer
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Transit-Amplifying Cells Orchestrate Stem Cell Activity and Tissue Regeneration
Y. Hsu
,
Lishi Li
,
E. Fuchs
Cell
2014
Corpus ID: 8330928
Highly Cited
2008
Highly Cited
2008
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
G. von Minckwitz
,
S. Kümmel
,
+10 authors
M. Kaufmann
Journal of the National Cancer Institute
2008
Corpus ID: 19367420
BACKGROUND Patients with an early response to neoadjuvant chemotherapy have chemosensitive tumors and a high probability for a…
Expand
Highly Cited
2005
Highly Cited
2005
Adjuvant docetaxel for node-positive breast cancer.
Miguel Martín
,
T. Pieńkowski
,
+29 authors
C. Vogel
New England Journal of Medicine
2005
Corpus ID: 18890243
BACKGROUND We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and…
Expand
Highly Cited
2003
Highly Cited
2003
An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4
L. Lasagni
,
M. Francalanci
,
+11 authors
P. Romagnani
Journal of Experimental Medicine
2003
Corpus ID: 11733868
The chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC regulate lymphocyte chemotaxis, mediate vascular pericyte proliferation…
Expand
Highly Cited
2001
Highly Cited
2001
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
S. C. Kim
,
Dong Wook Kim
,
+4 authors
M. Seo
Journal of Controlled Release
2001
Corpus ID: 25705003
Highly Cited
1999
Highly Cited
1999
The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.
Alain Sauty
,
Michelle Dziejman
,
+5 authors
Andrew D. Luster
Journal of Immunology
1999
Corpus ID: 7301028
Recruitment of activated T cells to mucosal surfaces, such as the airway epithelium, is important in host defense and for the…
Expand
Highly Cited
1999
Highly Cited
1999
Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human…
S. Gasperini
,
M. Marchi
,
+7 authors
M. Cassatella
Journal of Immunology
1999
Corpus ID: 45667020
Monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein of 10…
Expand
Highly Cited
1987
Highly Cited
1987
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins
K. Teshigawara
,
H. M. Wang
,
K. Kato
,
Kendall A. Smith
Journal of Experimental Medicine
1987
Corpus ID: 15093062
A cell line established from a patient with acute lymphoblastic leukemia was found to express IL-2 binding sites with a novel…
Expand
Highly Cited
1985
Highly Cited
1985
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
J. Yodoi
,
K. Teshigawara
,
+7 authors
M. Tsudo
Journal of Immunology
1985
Corpus ID: 13147698
A continuous cell line (YT cells) with inducible receptor for T cell growth factor (TCGF)/interleukin 2 (IL 2) was established…
Expand
Highly Cited
1984
Highly Cited
1984
Expression of interleukin 2 receptors on activated human B cells
T. Waldmann
,
C. Goldman
,
+6 authors
W. Greene
Journal of Experimental Medicine
1984
Corpus ID: 86303853
Using anti-Tac, a monoclonal anti-interleukin 2 (IL-2) receptor antibody, we have explored the possibility that certain activated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE